Fierce Biotech November 30, 2023
Andrea Park

Several months after earning FDA clearance, a 3D-printed bone graft product is gaining steam, having now been used in a handful of surgical procedures.

The product in question is CMFlex, which was developed by Dimension Inx. It’s a synthetic bone graft material that’s customized to each individual patient and, once implanted, is designed to promote natural regeneration of the nearby bones.

CMFlex was cleared by the FDA in December 2022, making it the first 3D-printed regenerative bone graft product to earn a green light from the regulator. It’s indicated for use in surgeries to correct maxillofacial, mandibular and dental bone defects.

The synthetic material has now been used across all of those indications, according to an announcement this week from...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: 3D Printing, Provider, Technology
Related Articles:
How 3D Printing Impacts Radiology
Ricoh’s 3D Printing Improves Surgical Accuracy and Safety One Layer at a Time
3D-printed hydrogel enables continuous drug delivery via contact lens
Improved 3D printed blood vessels thanks to bioink with DNA
DNA-based bioink technology enables precise 3D-printing of blood vessels

Share This Article